RHONDA RICHARDSON: Open Payments
NPI 1457363780 · LAUREL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,588 in 86 payments from 16 companies in 2025. Trend: 2023 $1,285 · 2024 $1,186 · 2025 $1,588
Food & beverage: $1,588
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $439 |
| Janssen Biotech, Inc. | 10 | $240 |
| Madrigal Pharmaceuticals | 5 | $206 |
| Ardelyx, Inc. | 11 | $157 |
| QOL Medical, LLC | 8 | $136 |
| Aimmune Therapeutics, Inc. | 5 | $91 |
| Phathom Pharmaceuticals, Inc. | 8 | $74 |
| Ferring Pharmaceuticals Inc. | 3 | $47 |
| Lilly USA, LLC | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
Products named: RINVOQ, TREMFYA, REZDIFFRA, IBSRELA, Sucraid, VOQUEZNA, VOWST, CREON.
Industry payments across MS — which companies pay providers there.
